Sign in
4

Changes in Ownership

Chemomab Therapeutics Ltd. Filed Acc 0001104659-21-063814

Options or other derivatives

  • Chief Financial Officer acquired 35,653 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Fatal Sigal · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-05-07 Grant or award : show line 1 in the form Option to Purchase American Depositary Shares +35,653 35,653 D
Loading xslF345X03/tm2115776-1_4seq1.xml…